Plain-English translation of NCT06100991 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a research registry — not a drug trial — that invites patients with generalized pustular psoriasis to share their medical information and treatment history. Researchers will track how the disease progresses over time, which treatments work best, and what side effects or other health conditions develop. By joining, you help doctors better understand this rare and serious skin condition.
Generalized pustular psoriasis is a rare and poorly understood disease. Doctors need real-world information from patients like you to learn how the disease unfolds over time, which treatments are most effective, and how to improve care.
You likely qualify if…
You likely don't qualify if…
You will share your medical records, treatment history, and answer questionnaires about your symptoms and quality of life. Over time, researchers will track how your disease progresses, what medications you use, and any side effects or other health problems that develop. The registry may also connect your information to other health databases to provide a complete picture of your care and outcomes.
AI-generated summary from trial data · Aug 27, 2026 · Not medical advice
United States
Sponsor
CorEvitas
Enrollment target
~200 participants
Started
September 2023
Primary completion
December 2099
Age range
18 Years and older
Last updated on clinicaltrials.gov in August 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Generalized Pustular Psoriasis Registry Team
CorEvitas
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.